Olaf Schoeman
Olaf Schoeman publishes mostly in Economics and Econometrics, Infectious Diseases and Pathology and Forensic Medicine, on topics such as Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy and Pharmaceutical studies and practices.
- World rank
- #4,650,225 of 7,710,434 ranked researchers
- Rank in Netherlands
- #84,904 of 107,149
- Works
- 22
- Citations
- 202
- Citations per work
- 9.2
What does Olaf Schoeman research?
Olaf Schoeman's work is mostly in Medicine (36%), Economics, Econometrics and Finance (27%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences836.5%
- Medicine836.5%
- Everything else836.2%
- Social Sciences627.3%
- 1Economics and Econometrics27% of their works
- 2Infectious Diseases9% of their works
- 3Pathology and Forensic Medicine7% of their works
- 4Cardiology and Cardiovascular Medicine7% of their works
- 5Pediatrics, Perinatology and Child Health7% of their works
- 6Pulmonary and Respiratory Medicine6% of their works
Research topics
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Pharmaceutical studies and practices
- Antifungal resistance and susceptibility
- Nail Diseases and Treatments
- Parasitic Diseases Research and Treatment
- Amyotrophic Lateral Sclerosis Research
- Multiple Sclerosis Research Studies
Which keywords describe Olaf Schoeman's research?
The keywords of their largest research topics: Cost-effectiveness Analysis, Quality of Life, Drug Development Costs, Generic Drugs, Antifungal Therapy, Epidemiology, Off-Label Drug Use and Pediatric Pharmacokinetics.
- TDP-43
- Multiple Sclerosis
- Ivermectin
- Diagnostic Criteria
- Invasive Fungal Infections
- Pediatric Pharmacokinetics
- Epidemiology
- Generic Drugs
- Quality of Life
- Cost-effectiveness Analysis
- Drug Development Costs
- Antifungal Therapy
- Off-Label Drug Use
- Candidiasis
- Dermatophytes
- FUS/TLS
- Lymphatic Filariasis
- Onychomycosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Cost-effectiveness Analysis81 topic
- Quality of Life81 topic
- Drug Development Costs61 topic
- Generic Drugs61 topic
- Antifungal Therapy52 topics
- Epidemiology52 topics
- Off-Label Drug Use41 topic
- Pediatric Pharmacokinetics41 topic
- Candidiasis31 topic
- Invasive Fungal Infections31 topic
- Dermatophytes21 topic
- Diagnostic Criteria21 topic
- FUS/TLS21 topic
- Ivermectin21 topic
- Lymphatic Filariasis21 topic
- Multiple Sclerosis21 topic
- Onychomycosis21 topic
- TDP-4321 topic
Where does Olaf Schoeman work?
Olaf Schoeman's main affiliation in the publication record is Pharmerit (Netherlands), Netherlands.
How many publications and citations does Olaf Schoeman have?
OpenAlex counts 22 works and 202 citations for Olaf Schoeman, an h-index of 6, ranking #4,650,225 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Olaf Schoeman. Posts are plain text and can be reported.